Brief: Medigene And Cytovant Enter Agreement For DC Vaccine Manufacturing
20/10/2020 07:15
Oct 20 (Reuters) - MEDIGENE AG MDG1k.DE :
* CO, CYTOVANT ENTER INTO SERVICE AGREEMENT FOR DC VACCINE
MANUFACTURING PROCESS DEVELOPMENT
Source text for Eikon: ID:nPexw9kMGa
Further company coverage: MDG1k.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Medigene AG
See all newsBrief: Medigene Files Application For The Opening Of Insolvency Proceedings
Brief: Medigene Files Patent For Unique Nk-Specific TCR Construct With European Patent Office
Brief: Medigene AG Says Co Amends Financial Guidance For 2024
Brief: Medigene AG Expands Protection Of KRAS Library With Filing Of New Patent Application
Brief: Medigene H1 Revenue EUR 4.5 Million